MAP2K7 and central nervous system cancer: Additionally, miR-7 is reported to inhibit growth of glioma cells and xenograft models by blocking the phosphoinositide-3-kinase (PI3K)/protein kinase B (ATK) and Raf/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathways [45].